This one-hour, on-demand, journal article-based activity examines the risks associated with pregnancy and elective termination among females receiving treatment for substance use disorder (SUD) compared to those not in treatment.

This one-hour, on-demand, journal article-based activity examines findings from 22 published case reports on the effects of inhalant use during pregnancy. It explores the impact on maternal health, fetal development, neonatal outcomes, and early childhood.

This one-hour course equips healthcare professionals with practical strategies to navigate the complex challenges of buprenorphine prescribing for opioid use disorder (OUD) in both hospital and clinic settings.

This two-hour online course equips healthcare professionals with the essential knowledge, skills, and tools to effectively identify and treat women with substance use disorders (SUDs).

This four-episode podcast series focused on improving hospital and clinic-based buprenorphine treatment for OUD provides experts insights, practical strategies, and real-world approaches to overcoming common challenges.

This 8-hour, online course provides the education that is essential for providers to identify, assess, diagnose, and manage pregnant and postpartum patients with opioid use disorder (OUD).

This one-hour, on-demand, journal article-based activity presents original research on the impact of the opioid intervention court (OIC) as an alternative to traditional treatment courts for people with OUD who are involved with the criminal-legal system and at high risk of overdose. The OICs more rapidly link court participants to treatment in comparison to traditional drug courts. As the time between arrest and post-arraignment drug court entry is one of high risk and may suspend access to treatment for OUD, OICs may demonstrate improved ability to immediately stabilize and reduce overdose risk in court participants.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course focuses on the prevention and treatment of stimulant use disorders and will discuss topics such as new clinical practice guidelines, novel pharmacotherapies, methamphetamine-induced psychotic disorders, and more.

This 1-hour, on-demand session from the 2024 ASAM State of the Art Course covers most recent updates on emerging issues and advances in addiction medicine from the perspective of three major federal agencies: NIAAA, SAMHSA, and NIDA.

This 1-hour, on-demand session from the 2024 ASAM State of the Art Course outlines recent interesting findings and topics that have emerged, from differences in formulations and routes of administration to ways research may impact the future of policy.